Piyasa kapalı· · USD · Veriler gecikmeli olabilir
Fiyatlar gecikmeli olabilir ve yalnızca bilgilendirme amaçlıdır - yatırım tavsiyesi değildir.
Perrigo Company plc (NYSE: PRGO), a leading provider of consumer self-care products, today announced that Interim President and CEO Albert Manzone and CFO Eduardo Bezerra are scheduled to participate in investor meetings at the Barclays Global Consumer Conference on Thursday, September 10th, 2026.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Perrigo stock has fallen sharply over the past few years, yet the current valuation checks suggest the market may now be pricing it on the cheap side. After a period of weak long term returns, investors are weighing whether the recent bounce in the share price is the start of a re rating or just a short term reaction. The share price has declined 61.9% over the past 3 years, which sets expectations low and can create room for a valuation reset if fundamentals hold up. Future revenue growth...
Why Perrigo Stock Is Back in Focus After Q2 Earnings Perrigo (PRGO) is drawing fresh attention after second quarter 2026 adjusted earnings per share came in ahead of consensus, supported by strong Infant Formula sales and a reaffirmed full year outlook for declining net sales. For investors, this mix of outperformance on adjusted earnings, weaker overall sales and a maintained guidance range for net sales decline between 5.5% and 1.5% raises practical questions about how the stock’s recent...
Moby summary of Perrigo Company plc's Q2 2026 earnings call
Perrigo Co PLC (PRGO) navigates a challenging quarter with strategic wins in infant formula and innovation, despite a 3.1% core net sales dip.
The headline numbers for Perrigo (PRGO) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Perrigo Company plc (NYSE: PRGO) ("Perrigo" or the "Company"), a leading provider of Consumer Self-Care Products, today announced financial results from continuing operations for the second quarter ended June 27, 2026.
Üçüncü taraf yayıncıların bu şirket hakkındaki son başlıkları; Makkler'in kendi editoryal içeriğinden ayrı tutulur ve dış kaynağa yönlendirir. Başlıkların doğruluğu ilgili yayıncının sorumluluğundadır.